The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prostate specific antigen (PSA) screening from fingerstick blood: Initial validation of a point-of-care (POC) test.
 
Abdul Baseet Arham
No Relationships to Disclose
 
Balaji Srinivasan
Stock and Other Ownership Interests - CVS Health
 
Joseph Thomas
Stock and Other Ownership Interests - Pfizer; Stryker (I); Vor Biopharma
 
Antra Ganguly
No Relationships to Disclose
 
David Erickson
No Relationships to Disclose
 
Zhen Zhao
Employment - Trizyc diagnostics
Consulting or Advisory Role - ET Healthcare
Research Funding - Diasorin; ET Healthcare; Gator Bio; Roche
 
Rachel Geisel
No Relationships to Disclose
 
Zhengming Chen
Stock and Other Ownership Interests - Johnson & Johnson; Moderna Therapeutics
 
Christopher Barbieri
Consulting or Advisory Role - Pfizer
 
Alfred Winkler
Employment - NYU Langone Medical Center
Stock and Other Ownership Interests - Northern Lithotriptor
Travel, Accommodations, Expenses - EDAP Technomed Inc
 
Douglas Scherr
No Relationships to Disclose
 
Jim Hu
Consulting or Advisory Role - Intuitive Surgical; Pfizer
Speakers' Bureau - Genomic Health; Intuitive Surgical
Travel, Accommodations, Expenses - intuitive surgical; Intuitive Surgical
 
Ana Molina
No Relationships to Disclose
 
Cora Sternberg
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Foundation Medicine; Genzyme; Gilead Sciences; Immunomedics; IMPAC Medical Systems; Incyte; Janssen Oncology; Medscape; Merck; MSD; Pfizer; Roche; UroToday
Travel, Accommodations, Expenses - Merck
 
Scott Tagawa
Stock and Other Ownership Interests - Convergent Therapeutics
Consulting or Advisory Role - 4D Pharma; Abbvie; AIkido Pharma; Ambrx; Amgen; Astellas Pharma; Bayer; Bicycle Therapeutics; Blue Earth Diagnostics; Boston Scientific; Clarity Pharmaceuticals; Clovis Oncology; Convergent Therapeutics; Daiichi Sankyo; Dendreon; Endocyte; Exelixis; Genentech; General Electric; Genomic Health; Gilead Sciences; Hookipa Pharma; Immunomedics; Janssen; Karyopharm Therapeutics; Lantheus Medical Imaging; Medivation; Merck; Myovant Sciences; Novartis; Pfizer; POINT Biopharma; QED Therapeutics; Regeneron; Sanofi; Seagen; Telix Pharmaceuticals; Tolmar; TransThera Biosciences
Research Funding - Abbvie (Inst); Ambrx (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Janux Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); POINT Biopharma (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent Royalty from Immunomedics / Gilead
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Immunomedics; Merck; Sanofi; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ATLAB Pharma; Phosplatin Therapeutics
 
Saurabh Mehta
Stock and Other Ownership Interests - VitaScan
Patents, Royalties, Other Intellectual Property - Cornell University (Inst)
(OPTIONAL) Uncompensated Relationships - SM is an unpaid board member for a diagnostic start up focused on measurement of nutritional biomarkers at the point-of-care utilizing the results from his research.
 
David Nanus
Honoraria - Genentech
Consulting or Advisory Role - AstraZeneca; Janssen Scientific Affairs
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Exelixis (Inst); immumedics (Inst); Janssen (Inst); Novartis (Inst); pfizer (Inst); Sagimet Biosciences (Inst); Zenith Epigenetics (Inst)